Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Latest Articles

  • You have access
    Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
    I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
    The Journal of Rheumatology February 1 2001, 28 (2) 363-365;
  • You have access
    Minimal clinically important difference module: summary, recommendations, and research agenda.
    G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
    The Journal of Rheumatology February 1 2001, 28 (2) 452-454;
  • You have access
    Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
    Y Katayama and K Kohriyama
    The Journal of Rheumatology February 1 2001, 28 (2) 288-291;
  • You have access
    Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.
    P A Gordon, E Rosenthal, M A Khamashta and G R Hughes
    The Journal of Rheumatology February 1 2001, 28 (2) 366-369;
  • You have access
    Bone mineral density in patients with psoriatic arthritis.
    B Frediani, A Allegri, P Falsetti, L Storri, S Bisogno, F Baldi, P Filipponi and R Marcolongo
    The Journal of Rheumatology January 1 2001, 28 (1) 138-143;
  • You have access
    Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.
    D J Lovell, M Passo, E Giannini and H Brunner
    The Journal of Rheumatology January 1 2001, 28 (1) 220;
  • You have access
    Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
    T Ellingsen, A Buus and K Stengaard-Pedersen
    The Journal of Rheumatology January 1 2001, 28 (1) 41-46;
  • You have access
    Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.
    W P Maksymowych, R Lambert, G S Jhangri, S Leclercq, P Chiu, B Wong, S Aaron and A S Russell
    The Journal of Rheumatology January 1 2001, 28 (1) 144-155;
  • You have access
    Autoantibodies to CTLA-4 enhance T cell proliferation.
    T Matsui, K Nishioka, T Kato and K Yamamoto
    The Journal of Rheumatology January 1 2001, 28 (1) 220-221;
  • You have access
    Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    T M Dawson, G Starkebaum, B L Wood, R F Willkens and A M Gown
    The Journal of Rheumatology January 1 2001, 28 (1) 47-53;

Pages

  • Previous
  • Next
  • 1
  • …
  • 961
  • 962
  • 963
  • 964
  • 965
  • 966
  • 967
  • 968
  • 969

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire